The FDA approved Salix Pharmaceutical's new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.
Here's what you should know:
1. Plenvu additionally focuses on preparing the ascending colon.
2. If approved, Plenvu will tout the lowest total volume of solution for a bowel cleanser.
3. Salix expects an FDA decision in the first quarter of fiscal year 2018.
4. Salix is a subsidiary of Valeant Pharmaceuticals.